Deric Park, MD, discusses a phase 1/2 study of IGV-001, a novel treatment for glioblastoma.
Deric Park, MD
Deric Park, MD, is a neuro-oncologist at John Theurer Cancer Center, Hackensack University Medical Center, in Hackensack, NJ.
Articles by Deric Park, MD
Deric Park, MD, discusses what challenges remain in treating glioblastoma, as well as new avenues for research in this difficult disease.